2021
DOI: 10.3389/fimmu.2021.749317
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Features and Risk Factors for Active Tuberculosis in Takayasu Arteritis: A Single-Center Case-Control Study

Abstract: BackgroundsTakayasu arteritis (TAK) is a chronic, granulomatous vasculitis correlated with tuberculosis (TB). The two diseases share similar pathological characteristics and clinical manifestations which increase the difficulty to diagnose. Active tuberculosis (ATB) has implications for treatment strategies in TAK patients. Therefore, the investigation of clinical features and potential risk factors of ATB in TAK patients is vital.MethodsThe study reviewed hospitalized patients diagnosed with TAK in our hospit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
1

Year Published

2023
2023
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 25 publications
0
5
1
Order By: Relevance
“…Fortunately, she did not develop severe complications such as dissecting aneurysm, ocular, or skin TB complications reported in some cases [ 20 22 ]. We insist on the importance of focusing on and treating TB infections before starting corticosteroids and immunosuppressive treatment mainly in countries with high prevalence of TB [ 23 ]. Although there is no evidence that anti-TB therapy prevents TAK progression or its complications, the combination of corticosteroids and anti-TB drugs was efficient to control the disease activity observed in our patient [ 24 ].Glucocorticoids should be combined with immunosuppressive drugs including methotrexate, cyclophosphamide, or mycophenolate mofetil to control disease activity [ 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…Fortunately, she did not develop severe complications such as dissecting aneurysm, ocular, or skin TB complications reported in some cases [ 20 22 ]. We insist on the importance of focusing on and treating TB infections before starting corticosteroids and immunosuppressive treatment mainly in countries with high prevalence of TB [ 23 ]. Although there is no evidence that anti-TB therapy prevents TAK progression or its complications, the combination of corticosteroids and anti-TB drugs was efficient to control the disease activity observed in our patient [ 24 ].Glucocorticoids should be combined with immunosuppressive drugs including methotrexate, cyclophosphamide, or mycophenolate mofetil to control disease activity [ 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…This is a retrospective study conducted at Peking Union Medical College Hospital, which is a national referral center proficient in diagnosing and managing TAK with multidisciplinary team collaboration (9,(16)(17)(18)(19)(20) in China. This study was carried out in accordance with the tenets of the Helsinki Declaration and was approved by the Review Board of PUMCH (S-K2122).…”
Section: Methodsmentioning
confidence: 99%
“…A total of 852 TAK patients were finally recruited (670 female, 182 male), and the F:M ratio was 3.7:1. The median age (Q1,Q3) at onset was 25 (18,33) years for all TAK patients. The age at onset displayed no sex difference, with a median age at onset of 25 (17,33) for males and 25 (19,32) for females (P = 0.347).…”
Section: Demographic Data and Numano's Angiographic Classificationsmentioning
confidence: 99%
See 1 more Smart Citation
“…Adults with active TB were more likely to have fever, weight loss, cough, fatigue, and night sweating. Latent TB cases were not investigated or reported [22 ▪ ].…”
Section: Classification/diagnostic Criteria Of Medium-vessel and Larg...mentioning
confidence: 99%